Yes so my 7000 shares at $2.17/share in 2011 have now become 14 shares. The price has to go to $1000/share for me to get close to breaking even. #$%$?!?!?!
I originally purchased 7,000 shares in 2011 when the price was $2.17. Now 4 years later after the Perifosine failure and several dilutions and R/S's, my total holdings are 14 shares. What needs to happen for me to get some $$ back??
I had 1400 shares and now have 14 after R/S. How the hell can I get my $$ back on this one? Does the price have to go to like $800/share??
Same nonsense happened at Qcor without any good reason. When you think it should be up, it's down and when you think it should be down, it's up.
Never knew you had to know someone to reply to them. I was just making a point about price and value dumb #$%$!! I see your name on this board and you are a flip flopper. You don't know whether to like MNK or hate them.
Again, price is all about what the market will bear and what consumers are willing to pay.
Homebuilder, I agree with you 110%. It should be illegal to spew negative Shitron information for personal financial gain. Betting on companies to fail is just downright wrong!!!
You pay for generics in your health plan. Is that fair? Where do you go when generics or other branded meds fail? Acthar is a step therapy that is only used when other cheaper meds have failed. I don't see anything wrong with that at all. That's how medicine should be.
Hillary is a hypocrite. MNK is being greedy by charging so much for Acthar yet she charges $200k for a 30 minute speech?? Give me a #$%$ break!! Acthar has the potential to save a baby's life and restore normal brain function when they are being devastated by Infantile Spasms. Can the same be said of Hillary's speeches?? Acthar stops IS in it's tracks and there is nothing even close to being as effective. Can you put a price tag on a baby's brain health?? Acthar is priced according to the value it provides for patients and what the market will bear. Remember, it is used only after cheap standards of therapy have failed, thus limiting it's market size.
The forum for this debate was absolutely disgusting!! CNBC should be ashamed of themselves for forcing the moderators to frame every question in such a negative, liberal biased way. I guarantee questions won't be asked like that for the Dem debates!!
He's a dumb dumb. I can't believe people actually take his advice. Pretty scary!!
I totally agree with you on this. I believe that most of that market share will come at the expense of other MS products not owned by Biogen : )
Hey preacher, have you realized yet that you are only talking to yourself?? Post after post of all nonsense with no responses from other ppl. You must be very lonely or very dumb!!
They all slow the progression of the disease but some may do it better. The data shows that Ocrelizumab will work as well as the newer oral meds, better than the old ABCR's but not as good as Tysabri or Lemtrada. Remember with better efficacy comes inferior safety, that's what weighs into a neurologist's decision when choosing a medicine for MS.